Find out how 10x Genomics and Dana-Farber aim to transform cancer diagnostics using spatial biology and single cell profiling for real-world clinical decisions.
Pierre Fabre joins forces with Iktos to discover AI-designed oncology drugs. Find out what this means for cancer R&D, regulatory strategy, and pipeline speed.
Find out how zenocutuzumab could change treatment strategies in NRG1+ pancreatic cancer after progression. Explore new ASCO GI 2026 data today.
bit.bio raised $50M to expand its human cell programming platform for toxicology and AI model training. Find out why investors are backing NAMs now.
Ventaris Surgical raises $30M to advance its kidney stone treatment system. Find out how it could reshape ureteroscopy outcomes in 2026.
Mu Medical unites Nanodropper, Bedo, and Viseon into a precision eyecare platform. Find out what this could mean for the future of AI-led ophthalmology.
Phanes’ spevatamig + chemo combo shows 40% ORR in mPDAC. Find out why this bispecific antibody may change frontline pancreatic cancer treatment.
Princeton Radiology acquires two centers from RAI—see how this move reshapes outpatient imaging strategy, tech, and patient services in New Jersey.
Visby’s at-home PCR STI test now on Quest and Labcorp. Find out how this redefines women’s health diagnostics and access. Read the full analysis.
AMRA and Prescan launch a first-in-Netherlands MRI scan to assess fat and muscle composition. Learn how this could redefine early disease detection in Europe.